This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Profit from These ETFs on Silver's "Short Squeeze" Buzz
by Sweta Killa
We have highlighted five silver ETFs that led the way higher on the short squeeze buzz and could be compelling choices to play the trend in the days ahead.
Silver Mining ETF Tops in July: 5 Stock Winners
by Sweta Killa
The twin tailwinds of rebounding industrial and manufacturing demand, and resurgence of safe-haven demand due to surging COVID-19 cases led to the rally in silver price.
Silver ETFs That Topped Last Week
by Sweta Killa
Silver price soared 15% last week, bringing year-to-date gains of 28%. With this surge, the white metal is outpacing gold, which has rallied 24% so far this year.
3 Top Sector ETFs to Start Q3 With More Room for Growth
by Sanghamitra Saha
We entered the third quarter some weeks ago with no abatement (rather surges) on the virus front and several U.S. states reversing the course of economic reopening.
Here's Why Silver Outshining Gold ETFs
by Sanghamitra Saha
Gold is already hovering around a record high level and silver is hovering around a six-year high. But silver ETFs have rallied faster than gold in the past month.
Ride on the Silver Rally With These ETFs & Stocks
by Sweta Killa
Silver has been on a stellar ride with prices climbing to the highest level in nearly four years. Notably, the precious metal has climbed 68% since mid-March.
ETFs Ways to Tap the Rise in Silver Price
by Sweta Killa
Silver gained nearly 24% in May, representing the biggest monthly jump in nearly a decade.
Silver Beat Gold ETFs Past Month: Here's Why
by Sanghamitra Saha
Silver started catching up with the gold rally and has been outshining in recent weeks as economies are reopening.
Silver Mining ETF (SIL) Hits New 52-Week High
by Sanghamitra Saha
This silver mining ETF hits a new 52-week high. Are more gains in store for this ETF?
10 ETFs Up More Than 30% in a Month
by Sweta Killa
The stabilization in the spread of the disease, hopes for re-opening of the economy anytime soon, and increased progress of drugmakers' to develop COVID-19 treatment has boosted confidence in the stock market.